English  |  正體中文  |  简体中文  |  2817635  
???header.visitor??? :  27812316    ???header.onlineuser??? :  499
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"langer c j"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-04-23T05:56:26Z Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC Awad M.M.;Gadgeel S.M.;Borghaei H.;Patnaik A.;Chih-Hsin Yang;Powell S.F.;Gentzler R.D.;Martins R.G.;Stevenson J.P.;Altan M.;Jalal S.I.;Panwalkar A.;Gubens M.;Sequist L.V.;Saraf S.;Zhao B.;Piperdi B.;Langer C.J.; Awad M.M.; Gadgeel S.M.; Borghaei H.; Patnaik A.; CHIH-HSIN YANG; Powell S.F.; Gentzler R.D.; Martins R.G.; Stevenson J.P.; Altan M.; Jalal S.I.; Panwalkar A.; Gubens M.; Sequist L.V.; Saraf S.; Zhao B.; Piperdi B.; Langer C.J.
臺大學術典藏 2020-05-26T09:26:44Z Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study Keynote-021 Investigators;Gandhi L;Raftopoulos H;Ge Y;Fiore J;Awad M.M;Sequist L.V;Gubens M;Chih-Hsin Yang;Panwalkar A;Jalal S.I;Stevenson J.P;Martins R.G;Gentzler R.D;Powell S.F;Patnaik A;Papadimitrakopoulou V.A;Borghaei H;Gadgeel S.M;Langer C.J; Langer C.J; Gadgeel S.M; Borghaei H; Papadimitrakopoulou V.A; Patnaik A; Powell S.F; Gentzler R.D; Martins R.G; Stevenson J.P; Jalal S.I; Panwalkar A; CHIH-HSIN YANG; Gubens M; Sequist L.V; Awad M.M; Fiore J; Ge Y; Raftopoulos H; Gandhi L; KEYNOTE-021 investigators
臺大學術典藏 2020-05-26T09:26:25Z Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non?�small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study Papadimitrakopoulou V.;Raftopoulos H;Saraf S;Bachman R;Sequist L.V;Chih-Hsin Yang;Hauke R;Gubens M;Villaruz L.C;Patnaik A;Borghaei H;Gandhi L;Langer C.J;Stevenson J.P;Gadgeel S.M; Gadgeel S.M; Stevenson J.P; Langer C.J; Gandhi L; Borghaei H; Patnaik A; Villaruz L.C; Gubens M; Hauke R; CHIH-HSIN YANG; Sequist L.V; Bachman R; Saraf S; Raftopoulos H; Papadimitrakopoulou V.
臺大學術典藏 2020-05-26T09:26:24Z 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non?�Small Cell Lung Cancer Borghaei H;Langer C.J;Gadgeel S;Papadimitrakopoulou V.A;Patnaik A;Powell S.F;Gentzler R.D;Martins R.G;Stevenson J.P;Jalal S.I;Panwalkar A;Chih-Hsin Yang;Gubens M;Sequist L.V;Awad M.M;Fiore J;Saraf S;Keller S.M;Gandhi L.; Borghaei H; Langer C.J; Gadgeel S; Papadimitrakopoulou V.A; Patnaik A; Powell S.F; Gentzler R.D; Martins R.G; Stevenson J.P; Jalal S.I; Panwalkar A; CHIH-HSIN YANG; Gubens M; Sequist L.V; Awad M.M; Fiore J; Saraf S; Keller S.M; Gandhi L.
臺大學術典藏 2019-12-04T08:43:29Z Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer Chia-Yu Chu;Choi J.;Eaby-Sandy B.;Langer C.J.;Lacouture M.E.; CHIA-YU CHU; Choi J.; Eaby-Sandy B.; Langer C.J.; Lacouture M.E.
臺大學術典藏 2019-12-04T08:43:29Z Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer Chia-Yu Chu;Choi J.;Eaby-Sandy B.;Langer C.J.;Lacouture M.E.; CHIA-YU CHU; Choi J.; Eaby-Sandy B.; Langer C.J.; Lacouture M.E.

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page